Red Violet, Inc. (RDVT)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
Intact: The reason to own it still holds.
Red Violet grows revenue about 17% a year. Profit margins aim for mid- to high-30% EBITDA. The company buys back stock with $30 million authorized. Earnings beats show solid execution.
Growth could slow below 10%. Margins may compress from cost pressures. The stock trades expensive at 54x PE, risking a valuation reset.
The price sits about 43% above our fair value near $46. Analysts expect 17% revenue growth, which we see as achievable but fully valued.
Breaks if: Company cancels or materially reduces buyback program
Breaks if: Adjusted EBITDA margin falls below 30% next year
Breaks if: YoY revenue growth falls below 10% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on revenue growth and margin improvement. The current thesis state is intact, supported by recent earnings beats and consistent execution of management priorities.
The market currently prices RDVT at an expensive valuation compared to its peers, reflecting a durable premium. There is an expectations gap of 0.26, indicating that the market anticipates continued strong performance.
Fundamentals are likely to remain strong in the near term, as management is on track with its priorities of driving revenue growth and improving EBITDA margins. However, there is a low probability of missing earnings expectations, which could introduce some risk.
The long-term thesis hinges on several factors, including the potential for the Fed to cut rates, which could benefit RDVT and other tech stocks. Additionally, the performance of sector leaders like SAP, CRM, and NOW will be crucial for maintaining momentum.
The most important moves since the prior daily snapshot.
Valuation fell by 13.5 points (from 28.5 to 15.0).
Yes, our read has strengthened. The latest earnings beat supports the growth thesis. Record revenue reinforces the company's growth objectives. There are no new threats impacting the outlook.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Overall, RDVT's strong recent performance and management execution are promising, but the elevated valuation and near-term risks warrant careful observation. Not investment advice.